Novo Nordisk's Pill, BMW's Struggle, Diageo Up

Stock Movers

On this episode of Stock Movers:
- Novo Nordisk’s new Wegovy obesity pill fueled sales in the first quarter and the drugmaker said this year’s declines won’t be as bad as expected, a relief for investors.
- BMW’s carmaking returns fell in the first quarter as intense competition in China weighed on prices and deliveries in the world’s biggest auto market.
- Diageo’s sales unexpectedly rose in the latest quarter as growth in Africa and Latin America was enough to offset significant weakness in the US.

See omnystudio.com/listener for privacy information.

More description

On this episode of Stock Movers:
- Novo Nordisk’s new Wegovy obesity pill fueled sales in the first quarter and the drugmaker said this year’s declines won’t be as bad as expected, a relief for investors.
- BMW’s carmaking returns fell in the first quarter as intense competition in China weighed on prices and deliveries in the world’s biggest auto market.
- Diageo’s sales unexpectedly rose in the latest quarter as growth in Africa and Latin America was enough to offset significant weakness in the US.

See omnystudio.com/listener for privacy information.

2026-05-06 4 min Transcript
Listen elsewhere

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

Open the Transcript tab to load the transcript.

Chapters

No chapters available.